Immunophenotyping, Part II: Analysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells.

Autor: Newton HS; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Zhang J; Agilent Technologies, Santa Clara, CA, USA., Dobrovolskaia MA; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. marina@mail.nih.gov.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2024; Vol. 2789, pp. 269-291.

Multicolor flow cytometry-based immunophenotyping for preclinical characterization of nanotechnology-based formulations: an insight into structure activity relationship and nanoparticle biocompatibility profiles.

Autor: Newton HS; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Zhang J; Agilent Technologies, Santa Clara, CA, United States., Donohue D; Statistics Department, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Unnithan R; Statistics Department, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Cedrone E; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Xu J; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Vermilya A; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Malys T; Statistics Department, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Clogston JD; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States., Dobrovolskaia MA; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD, United States.

Publikováno v: Frontiers in allergy [Front Allergy] 2023 Jul 04; Vol. 4, pp. 1126012. Date of Electronic Publication: 2023 Jul 04 (Print Publication: 2023).

How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity.

Autor: Chirra M; Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.; Division of Hematology-Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Newton HS; Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Gawali VS; Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Wise-Draper TM; Division of Hematology-Oncology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Chimote AA; Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA., Conforti L; Division of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.

Publikováno v: Cancers [Cancers (Basel)] 2022 Jul 22; Vol. 14 (15). Date of Electronic Publication: 2022 Jul 22.

Immune Checkpoint Inhibitors Regulate K ⁺ Channel Activity in Cytotoxic T Lymphocytes of Head and Neck Cancer Patients.

Autor: Gawali VS; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH, United States., Chimote AA; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH, United States., Newton HS; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH, United States., Feria-Garzón MG; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH, United States., Chirra M; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH, United States., Janssen EM; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.; Immunology, Janssen Research and Development, Spring House, PA, United States., Wise-Draper TM; Department of Internal Medicine, Division of Hematology Oncology, University of Cincinnati, Cincinnati, OH, United States., Conforti L; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH, United States.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2021 Aug 27; Vol. 12, pp. 742862. Date of Electronic Publication: 2021 Aug 27 (Print Publication: 2021).

Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier.

Autor: Avila YI; Nanoscale Science Program, Department of Chemistry, University of North Carolina Charlotte, Charlotte, NC 28223-0001, USA., Chandler M; Nanoscale Science Program, Department of Chemistry, University of North Carolina Charlotte, Charlotte, NC 28223-0001, USA., Cedrone E; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD 21702, USA., Newton HS; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD 21702, USA., Richardson M; Nanoscale Science Program, Department of Chemistry, University of North Carolina Charlotte, Charlotte, NC 28223-0001, USA., Xu J; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD 21702, USA., Clogston JD; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD 21702, USA., Liptrott NJ; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L7 3NY, UK., Afonin KA; Nanoscale Science Program, Department of Chemistry, University of North Carolina Charlotte, Charlotte, NC 28223-0001, USA., Dobrovolskaia MA; Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, MD 21702, USA.

Publikováno v: Molecules (Basel, Switzerland) [Molecules] 2021 Jan 27; Vol. 26 (3). Date of Electronic Publication: 2021 Jan 27.